GAMCO Investors’s Biolase, Inc. BIOL Stock Holding History

GAMCO Investors’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8	Closed	-$24K	–	862
2018 Q2	$24K	Sell	8 -3	-27%	-$11.3K	﹤0.01%	849
2018 Q1	$55K	Hold	11	–	–	﹤0.01%	827
2017 Q4	$57K	Buy	11 +3	+38%	+$21.1K	﹤0.01%	834
2017 Q3	$60K	Buy	8 +1	+14%	+$8.62K	﹤0.01%	839
2017 Q2	$88K	Hold	7	–	–	﹤0.01%	831
2017 Q1	$123K	Hold	7	–	–	﹤0.01%	822
2016 Q4	$127K	Hold	7	–	–	﹤0.01%	794
2016 Q3	$160K	Hold	7	–	–	﹤0.01%	785
2016 Q2	$107K	Hold	7	–	–	﹤0.01%	796
2016 Q1	$120K	Hold	7	–	–	﹤0.01%	779
2015 Q4	$77K	Hold	7	–	–	﹤0.01%	800
2015 Q3	$82K	Hold	7	–	–	﹤0.01%	815
2015 Q2	$159K	Hold	7	–	–	﹤0.01%	806
2015 Q1	$185K	Hold	7	–	–	﹤0.01%	801
2014 Q4	$241K	Hold	7	–	–	﹤0.01%	796
2014 Q3	$228K	Hold	7	–	–	﹤0.01%	820
2014 Q2	$201K	Hold	7	–	–	﹤0.01%	838
2014 Q1	$220K	Hold	7	–	–	﹤0.01%	800
2013 Q4	$258K	Sell	7 -1	-13%	-$23.7K	﹤0.01%	771
2013 Q3	$183K	Hold	8	–	–	﹤0.01%	797
2013 Q2	$342K	Buy	+8	New	+$447K	﹤0.01%	711

Other funds holding BIOL

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TMC

Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

TFO

Tarbox Family Office Newport Beach, California $616M AUM 18.34% 1-Year Est. Return

GAMCO Investors's BIOL Position: Q3 2018 in Review

GAMCO Investors sold out of Biolase, Inc. (BIOL) in Q3 2018, closing a stake of 8 shares — an estimated $24K sold.

GAMCO Investors first reported a position in BIOL in Q2 2013 and held it in 21 quarters. The position peaked at $342K in Q2 2013. 15 funds tracked by Wall St. Rank hold BIOL as of Q3 2018.

GAMCO Investors reported no remaining Biolase, Inc. position as of Q3 2018 after selling out during the quarter.
GAMCO Investors sold 8 Biolase, Inc. shares in Q3 2018, an estimated $24K.
GAMCO Investors first reported a position in Biolase, Inc. in Q2 2013 and held it in 21 quarters.
GAMCO Investors's Biolase, Inc. position peaked at $342K in Q2 2013.
15 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2018.

Based on GAMCO Investors's 13F filing for Q3 2018, filed 2 Nov 2018.